Details of the Drug Reposition

General Information of This Drug (ID: DM3ZLTB)

Drug Name
PVSRIPO   DM3ZLTB
Drug Type
Vaccine

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Glioblastoma of brain DISESTHB 2A00.00 Phase 2 [1]
Melanoma DIS1RRCY 2C30 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04479241) PVSRIPO and Pembrolizumab in Patients With Recurrent Glioblastoma. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04577807) LUMINOS-102: PVSRIPO With or Without Immune Checkpoint Blockade in Patients With Advanced PD-1 Refractory Melanoma. U.S. National Institutes of Health.